Butterfly Pea for Hair and Skin, and Its Safety Profile
Butterfly pea occupies a whole shelf of the hair-care aisle. Blue shampoos, blue scalp oils, blue masks, and a claim — usually phrased as "traditionally used to strengthen hair and prevent greying" — that traces back to genuine Thai and Ayurvedic practice. The tradition is real. The clinical evidence for it is close to nonexistent, and the honest version of the story is more interesting than the marketing version, because it separates three completely different things that get sold as one: a documented traditional practice, a colour-deposit cosmetic effect that is real but is not hair growth, and a set of in-vitro mechanisms that have never been tested on a human head.
The second half of this page is the safety profile, and it needs a specific kind of care. Butterfly-pea flower has a good record: centuries of culinary use across Southeast Asia, no pattern of harm, and no adverse events in the one small drinking trial that reported on them. That is genuinely reassuring, and it is also "no signal found", not "proven safe" — a distinction that matters most for the concentrated extracts and capsules nobody has studied for chronic use. There are also three specific things worth knowing: the seeds and root are traditionally purgative and are not the tea, there is no human safety data for concentrated extracts in pregnancy, and most "blue tea" on sale is dried flower while a fair amount of it is a blend.
Table of Contents
- Where the Hair Claim Comes From
- Topical Versus Oral: Two Different Questions
- The Hair Evidence, Tier by Tier
- What Blue Shampoo Actually Does
- Skin: Pigments, Ultraviolet and Glycation
- Safety: What "No Signal" Means and What It Does Not
- The Seeds and Root Are Not the Tea
- Pregnancy, Breastfeeding and Children
- Medication Interactions and Surgery
- Allergy and the Legume Question
- Buying and Reading a Blue-Tea Label
- The Bottom Line
- Key Research Papers
- Connections
- Featured Videos
Where the Hair Claim Comes From
Two separate traditions converge here, and both are genuine documented practice rather than modern invention. Tier: traditional use only.
Thai practice. In Thai traditional medicine anchan — the butterfly-pea flower — is applied to hair and scalp, and the flowers are rubbed into the hair or infused into a rinse. Depending on the source the stated intention is darkening or brightening the hair, encouraging growth, or supporting scalp condition. This is a long-standing everyday practice in Thailand rather than a fringe one, and it is the direct ancestor of the modern blue-shampoo category. It is worth noting the aesthetic logic: a deep blue-violet pigment applied to dark hair is a plausible way to deepen the appearance of black hair, and the tradition may well be describing a cosmetic effect accurately.
Ayurvedic practice. Aparajita appears in Indian hair-oil traditions, generally as one component of a compound oil infused with several herbs. The relevant Ayurvedic framing is usually about scalp condition and premature greying rather than about regrowth in pattern baldness — a distinction that modern marketing tends to collapse.
What the tradition supports and what it does not. Centuries of use is good evidence that applying butterfly-pea flower to a scalp does not commonly cause harm, and reasonable evidence that people found it worth continuing. It is not evidence of hair regrowth, of an effect on androgenetic alopecia, or of any effect on hair pigmentation biology. Traditional cosmetic practices frequently persist because they produce an immediate visible or tactile result — shine, colour, slip, scent — and that is a real benefit with a completely different mechanism from the one the packaging implies.
Topical Versus Oral: Two Different Questions
Butterfly pea is sold for hair in two entirely different formats, and almost everything written about it fails to separate them.
Topical. A rinse, oil, shampoo or mask applied to hair and scalp. Here the pigment is physically present on the hair shaft, and the relevant questions are cosmetic and dermatological: does it deposit colour, does it condition, does it irritate, does it stain. Absorption is largely irrelevant and the effects are mostly immediate and visible.
Oral. Drinking the tea or taking a capsule in the hope of affecting hair. Here every constraint from the antioxidant and metabolic claims page applies in full and then some. The compound has to survive digestion, be absorbed, reach the dermal papilla of a hair follicle, and act there at a meaningful concentration. Only a small percentage of ingested anthocyanin is absorbed intact; most is converted by gut bacteria into phenolic acids. There is no evidence that any of this reaches a hair follicle at a concentration that does anything.
The practical consequence: a topical butterfly-pea product can plausibly make your hair look better today, through pigment deposit and conditioning, and that is a real if modest cosmetic benefit. Drinking blue tea for your hair has no evidence behind it at all. If a product markets an ingestible for hair, that is the claim with nothing under it.
The Hair Evidence, Tier by Tier
Laid out honestly, from strongest to weakest, which in this case means from "documented practice" to "extrapolated mechanism".
- Traditional topical use in Thailand and India. Tier: traditional use only. Well documented, long-standing, widely practised. Supports tolerability. Does not establish any biological effect on hair growth.
- Cosmetic colour deposit and conditioning. Tier: physically demonstrable, cosmetic rather than therapeutic. A pigmented plant extract in a conditioning base deposits colour on the hair shaft and improves surface feel. This is the mechanism most blue hair products actually operate by, and it is not in dispute — it is simply not what "strengthens hair" implies.
- In-vitro and animal reports of hair-growth-related activity. Tier: preliminary. A small number of published reports have examined butterfly-pea extracts in hair-related models — effects on follicle cells in culture, effects in rodent hair-growth models, and inhibition of enzymes such as 5α-reductase in cell-free assays. This literature is thin, heterogeneous and mostly published in specialist cosmetic-science venues. Read it as hypothesis generation. Anyone quoting a specific percentage improvement in hair growth from this literature is over-reading it, and figures of that kind hold up only as far as the original paper does.
- Antioxidant reasoning applied to follicles. Tier: not established. "Oxidative stress contributes to hair loss and greying, butterfly pea is antioxidant, therefore it helps" inherits every problem set out on the antioxidant page, plus the delivery problem: getting a large, polar, glycosylated pigment from a shampoo bottle through the stratum corneum to a follicle bulb is a genuine formulation challenge that a colour claim does not address.
- Prevention of greying. Tier: not established. Hair greying is driven by depletion and dysfunction of follicular melanocyte stem cells, with a strong genetic component in the timing. No plant extract has been shown to reverse or prevent it in a controlled human trial. A blue-violet pigment can make grey hair look different — which is exactly what a toning product does, and which is not the same claim.
- Human clinical trials of butterfly pea for hair. None published. No randomized controlled trial of any butterfly-pea preparation for hair growth, hair loss, hair density or greying exists in the accessible literature. One 2024 scalp trial did test a butterfly-pea shampoo, for dandruff (below).
The one scalp trial: dandruff. A 2024 study at a hospital skin clinic in Pekanbaru, Indonesia, gave 70 women aged 18–25 with dandruff either a shampoo made with 20% butterfly-pea flower or a standard 2% ketoconazole (antifungal) shampoo. Dandruff severity scores and patient satisfaction came out similar in the two groups (p=0.115 and p=0.336). The butterfly-pea shampoo lowered scalp oil (sebum) more (1.16% versus 0.22%, p<0.001), while the antifungal shampoo lowered the DNA of the dandruff yeast (Malassezia) more (p=0.008). Side effects were more common in the antifungal-shampoo group (reported in 21.2% of the patients). The abstract describes a before-and-after comparison of two groups and does not mention randomization. This is a dandruff result, not a hair-growth result.
The fair summary: a blue hair product will very likely make hair look and feel fine, and the risk is low. For actual hair loss, butterfly pea is not a tested treatment, and pattern hair loss in particular has treatments with real trial evidence.
What Blue Shampoo Actually Does
Worth a short section because the answer is genuinely useful and has nothing to do with herbal medicine. This is colour theory.
On the colour wheel, blue and violet sit opposite yellow and orange. Depositing a small amount of blue or violet pigment onto hair visually cancels yellow and brassy orange tones. This is why purple shampoo is a staple for blonde and grey hair, and why blue shampoo is used on lightened brown hair where the unwanted tone is orange rather than yellow.
A butterfly-pea-tinted shampoo does this, and does it as a genuine pigment rather than a synthetic dye, which is a real selling point for anyone avoiding synthetic colourants. It is a toning product. It changes how existing hair looks, immediately and temporarily, and it washes out.
Two practical notes follow from the chemistry on the colour-change page:
- The pH of the product changes the colour it deposits. Most shampoos and conditioners are formulated mildly acidic, around pH 4.5–5.5, to keep the hair cuticle closed. At that pH butterfly-pea pigment is violet rather than blue — which is fine, and is usually what a toning product wants, but it means the colour in the bottle is not the colour of the infusion.
- Very porous, light or chemically treated hair can hold the tint longer than intended and go visibly blue-grey. This is a known behaviour of any pigmented toning product on damaged hair, not a defect. Less product and a shorter time on the hair deposit less tint.
None of this is a health effect, and none of it needs to be. A product that makes your hair look better is doing something useful. It is just not doing what "strengthens hair from within" says.
Skin: Pigments, Ultraviolet and Glycation
Tier: preliminary (in vitro), with no human trials of butterfly pea for these skin uses.
Butterfly-pea extract appears in serums, masks and creams, usually with one of three rationales. Each is worth stating with its actual support level:
- Antioxidant protection. The extract scores on antioxidant assays, and topical antioxidants are an established idea in dermatology — vitamin C and vitamin E have real formulation science behind them. But the specific claim for butterfly pea rests on assay data rather than on skin studies, and a topical antioxidant's usefulness depends heavily on stability in the formulation, penetration and concentration, none of which follow from an assay result.
- Anti-glycation. Some plant polyphenols inhibit the formation of advanced glycation end-products in vitro, and glycation of dermal collagen is a real contributor to skin ageing. Butterfly-pea extract has been reported to show anti-glycation activity in cell-free systems. The gap between a cell-free assay and dermal collagen in a living person is very wide.
- Photoprotection. Anthocyanins absorb visible and some ultraviolet light, and topical anthocyanin preparations have been explored for photoprotective effects in preliminary work. This is nowhere near sunscreen. No butterfly-pea product has been tested as sun protection in people; the tested level of protection is what a sunscreen's measured sun protection factor (SPF) states.
A laboratory skin-safety study. A 2026 study tested two butterfly-pea flower extracts, a traditional water extract and an ethanol extract, with standard laboratory skin-safety methods validated by the Organisation for Economic Co-operation and Development (OECD). Both extracts were non-sensitising, and in a diffusion-cell skin-absorption test neither showed systemic exposure. The ethanol extract was phototoxic (reacted harmfully with light) at high concentrations. These are test-tube and cell results, not human patch tests.
What is reasonably safe to say: butterfly-pea extract in a cosmetic is a plant extract with a pleasant colour and no notable irritancy signal, in a product whose benefit will come mostly from its base — the humectants, emollients, occlusives and any actives with real dermatological evidence. The rest of the formula decides what a butterfly-pea skincare product does; the blue is decoration. A patch test on a small area is the standard check for a skin reaction to a new botanical product, which matters most for people with eczema or sensitive skin, because botanical extracts as a class are a more common source of contact sensitisation than simple synthetic ingredients.
Safety: What "No Signal" Means and What It Does Not
This is the most important section on the page, and it turns on one distinction.
What the record actually contains:
- Centuries of culinary use. Butterfly-pea flowers have coloured rice, cakes and drinks across Thailand, Malaysia, Indonesia and Vietnam for a long time, in ordinary food, eaten by everyone including children. No pattern of harm has emerged from that.
- No adverse events in the controlled drinking trials. Two small Thai crossover trials, totalling roughly thirty participants, each lasted a few hours: one gave 15 healthy young men 1 g or 2 g of flower extract in water and reported no adverse events; the other gave 16 overweight or obese men 1 g or 2 g with a high-fat meal, found no change in after-meal glucose but lower after-meal triglycerides with 2 g, and did not report on adverse events.
- Regulatory acceptance as a colour. In the United States, federal rule 21 CFR 73.69 lists butterfly pea flower extract (a water extract of the dried flowers) as a colour additive exempt from certification. It was first issued in September 2021 and amended in May 2025; the permitted uses now include alcoholic beverages, sport and energy drinks, flavoured or carbonated water, fruit drinks, soft drinks, fruit and vegetable juice, nutritional beverages, teas, chewing gum, coated nuts, liquid coffee creamers, ice cream, hard and soft candy, dairy and non-dairy drinks, fruit preparations in yogurt, ready-to-eat cereals, crackers, snack mixes, pretzels and some chips. Status differs by jurisdiction and category. A regulator permitting a colourant in specified foods is a real, if narrow, safety assessment — narrow because it applies to colourant-level exposure, not to a daily gram of concentrated extract.
- Sparse animal toxicology. The published acute and sub-chronic toxicity work on Clitoria ternatea extracts is limited and mostly reports no adverse effect at the doses tested.
What that record is: the absence of a detected signal. It is a genuinely good starting position and it is the reason nothing on this page is alarmist.
What that record is not: a completed safety assessment. And the difference is not pedantry — it is a statement about what the existing data could have detected:
- Traditional use detects acute, common, obvious harm. If a food made a noticeable fraction of people vomit, it would have been dropped centuries ago. Traditional use is a good detector for that and a poor detector for a slow effect, a rare effect, an effect on a specific vulnerable group, or an interaction with a modern medicine that did not exist when the tradition formed.
- The exposure levels are different by a large factor. A pinch of flower colouring a dish is not one to two grams of concentrated extract taken daily. Culinary safety does not transfer up the dose curve, and a concentrate is a different exposure from the food it came from.
- Thirty people for a few hours cannot detect much. That sample and duration would miss anything uncommon, anything cumulative, and anything requiring repeat dosing to appear.
- There is no chronic human data at all. No study of daily concentrated extract over weeks or months. No established upper limit. No liver or kidney monitoring data. No data in older adults, in people with chronic disease, or in anyone taking multiple medications.
- One genuinely open question. Butterfly pea makes cyclotides — small cyclic peptides knotted by three disulfide bonds, remarkably resistant to heat and digestion, with insecticidal activity that underpins a commercial bio-insecticide. Their behaviour after human ingestion is not established. This is not a known problem; it is an honest acknowledgement that an unusually digestion-resistant peptide class in a plant people are now consuming as concentrated extract has not been characterised in humans. It is a reason for interest and a reason not to overstate the safety picture for concentrates.
The practical translation. Drinking butterfly-pea tea or eating blue rice sits comfortably within the record above and requires no particular caution for most people. Taking gram-scale concentrated extract daily for months is a decision made in the absence of data; the safety record of the food does not carry over to it.
The Seeds and Root Are Not the Tea
This is the single most concrete safety point about the plant, and it is routinely lost because everything is sold under one name.
Clitoria ternatea seeds have a well-documented traditional reputation as a purgative — a laxative and emetic — and in quantity can cause nausea, vomiting, abdominal cramping and diarrhoea. That is a traditional use in some contexts rather than a poisoning, but it is emphatically not what someone brewing a flower tea is looking for. The root also has purgative and emetic uses in traditional practice and is the material behind most of the rodent memory literature discussed on the cognition page.
What this means when you buy:
- Flowers are the beverage part. "Clitoria ternatea dried flowers" or "butterfly-pea flower tea" is how a flower product is labelled.
- "Whole plant" on a beverage product means more than flower. Whole-plant material may include root, stem, leaf and seed. That is a legitimate description for some traditional preparations and it is not flower tea.
- Pods and seeds from a garden vine are not the tea. The vine is widely grown ornamentally and sets flat pea pods. Very young tender pods are eaten as a vegetable in parts of Southeast Asia; mature seeds are the purgative material. The flowers are the part brewed as tea.
- The plant part on a capsule label matters. "Clitoria ternatea extract" with no part stated tells you nothing, and root and flower have different profiles and different traditional cautions.
Pregnancy, Breastfeeding and Children
Pregnancy. The distinction between food and concentrate carries the whole answer here.
- Culinary amounts — a cup of flower tea, blue rice, a coloured dessert — are traditional across Southeast Asia and are consumed by pregnant women there as ordinary food. There is no signal of harm at that level.
- Concentrated extracts, capsules and supplements: no human safety data. There is no human safety data in pregnancy at those doses, and for a concentrated botanical with no pregnancy data, that absence is the whole safety picture.
- There is a specific reason for caution beyond the general principle. Some traditional Indian sources list aparajita preparations among plants used to stimulate the uterus or to influence menstruation. Whether that reflects a real pharmacological property of any particular preparation is not established, and traditional emmenagogue and abortifacient reputations are frequently unreliable — but a reputation of that kind, attached to a plant with no pregnancy safety data, is an open question that no study has settled.
- Root and seed preparations carry the purgative concern above in pregnancy, as well as the reputational one.
Breastfeeding. Same structure and same conclusion: culinary amounts are traditional and unremarkable; there is no human safety data on concentrated extracts during breastfeeding.
Children. Blue rice, blue kuih and blue drinks are ordinary children's food in Malaysia, Thailand and Indonesia, and the colour-change demonstration on the chemistry page is a genuinely good and completely safe science activity for a child. Supplements are a different matter for children: there is no paediatric dosing data, no paediatric safety data, and no plausible reason for a child to take a concentrated botanical extract. The distinction is food versus supplement, and it is not a fine one.
Medication Interactions and Surgery
Presented in order of how much attention each actually deserves.
- Glucose-lowering medication — the one that matters. Butterfly-pea flower extract inhibits carbohydrate-digesting enzymes and reduced post-meal glucose and insulin in a human trial. It did not lower fasting glucose, which is reassuring. In that 2018 trial in 15 healthy men, 1 g and 2 g of extract taken with 50 g of sugar (sucrose) lowered the after-meal rise in glucose and insulin, while extract taken alone did not change fasting glucose or insulin. For people taking insulin or a sulfonylurea — glipizide, gliclazide, glimepiride — regular concentrated extract with meals adds a second after-meal glucose-lowering influence on top of the drug; no study has tested that combination. This is covered in full on the metabolic claims page.
- Existing α-glucosidase inhibitors. If you already take acarbose, miglitol or voglibose, adding a weak botanical inhibitor may add gas, bloating and loose stools without adding benefit.
- Anticoagulants and antiplatelet drugs. Polyphenol-rich extracts are frequently flagged as a theoretical platelet-function concern as a class. For butterfly pea specifically, a 2008 review of the plant lists blood platelet aggregation-inhibiting activity among the activities reported for its extracts in pharmacological studies. No human study of an interaction with warfarin, a direct oral anticoagulant or antiplatelet therapy was found; the concern is that activity added to a drug whose purpose is to slow clotting.
- Surgery. Stopping concentrated botanical extracts around two weeks before planned surgery is the standard general precaution in surgical practice for any supplement with plausible glucose or platelet effects; for butterfly pea it is about being conservative around anaesthesia rather than about a documented problem.
- Blood-pressure and lipid medication. Some in-vitro work reports blood-pressure-relevant and low-density lipoprotein-oxidation-relevant activity for butterfly-pea petal extracts. Test-tube findings, no human data, no established interaction. The open question is concentrated extract alongside tightly managed therapy, not tea-level use.
- The bigger practical risk is not an interaction at all. It is substitution — someone concluding that a herbal product is managing their diabetes, blood pressure or cholesterol and becoming less rigorous about medication, monitoring or diet. Nothing in the butterfly-pea literature supports replacing any part of prescribed care.
Allergy and the Legume Question
Clitoria ternatea is a member of the Fabaceae — the pea and bean family. That places it botanically alongside peanut, lupin, chickpea, lentil and pea, all recognised food allergens.
How much this matters, realistically:
- Botanical relatedness is a weak predictor of clinical cross-reactivity. Legume allergy is generally protein-specific, and being in the same family does not reliably mean shared allergenic epitopes. Plenty of people with peanut allergy eat other legumes without difficulty.
- An infusion carries little protein. A hot-water infusion of dried petals extracts mainly pigments, phenolics and soluble sugars. Protein content in the cup is minimal, which further lowers an already low risk.
- The theoretical risk is not zero. For people with a significant legume allergy, particularly a severe one, the exposure is smallest with a small first amount rather than a large pot, and oral tingling, itching or swelling are the early signs of an allergic reaction.
- Concentrated extracts and whole-plant powders carry more protein than an infusion does, and the cyclotide peptides mentioned earlier are notably digestion-resistant. For people with legume allergy, an infusion is the lower-risk format.
- Contact reactions from topical products are possible with any botanical extract. A patch test on a small area is the standard check for a new skincare or scalp product.
Buying and Reading a Blue-Tea Label
Practical, and directly connected to everything above.
- "Flower" and the binomial on the label. "Clitoria ternatea dried flowers" names both the plant and the part. A label with no plant part named does not say what is in the bag.
- Most commercial "blue tea" is straight dried flower, and a fair amount of it is a blend. Blends with lemongrass, pandan, hibiscus, ginger or lemon peel are common and often very good, and the ingredient list shows which — a hibiscus blend is acidic and will brew purple rather than blue, and people are frequently disappointed by that without understanding why.
- Colour shows the quality of dried flowers. Good stock is a deep indigo-blue. A faded grey-blue means old or light-damaged material that will brew weakly and taste flat.
- Heat and light degrade the pigment. Airtight, opaque, cool and dry storage keeps it longest.
- A product sold primarily on a health claim is a different thing from a food. A bag of flowers sold as tea is a food. A capsule sold as a memory supplement is making a claim with nothing behind it, at a dose nobody has studied for chronic use, usually without stating anthocyanin content or plant part.
- "Standardised extract" without a stated marker means nothing. Standardisation only has content if the label says standardised to what, at what percentage.
- Supplements are not pre-approved. In most jurisdictions a botanical supplement reaches the shelf without any regulator having assessed its efficacy or, in practice, verified its label. That is why plant part, binomial and stated marker matter — they are the only information you have.
The Bottom Line
- Topical butterfly pea is a cosmetic, and a reasonable one. It deposits blue-violet pigment, which tones brassiness and can deepen the look of dark hair, and it comes with centuries of traditional use and no notable irritancy signal. The product's base formula decides most of what it does.
- Drinking butterfly pea for your hair or skin has no supporting evidence. The absorption arithmetic is against it before you even reach the follicle.
- No clinical trial has tested butterfly pea for hair growth, hair loss or greying. One 2024 scalp trial tested a butterfly-pea shampoo for dandruff, and dandruff scores improved about as much as with a standard antifungal shampoo.
- The flower tea has a good safety record, and "good record" means no signal found. That is a real reassurance about food-level use and not a substitute for the chronic-use data that does not exist for concentrates.
- Seeds and root are purgative and are not the tea. The flowers are the beverage part.
- There is no human safety data for concentrated extracts in pregnancy, breastfeeding or children. Culinary amounts are traditional and unremarkable.
- Insulin and sulfonylureas are the interaction that matters. In a 2018 trial, 1 g and 2 g of extract taken with sugar lowered the after-meal rise in glucose and insulin, while extract alone did not change fasting glucose or insulin.
- Its real value is as a drink. A beautiful, caffeine-free, near-flavour-neutral drink with genuinely excellent chemistry in it and a real culinary history. That is a good enough reason on its own, and it happens to be the part that is actually true.
Key Research Papers
The first six entries link to their PubMed records. The rest are PubMed topic searches, where no single paper stands for the point.
- Mukherjee PK, Kumar V, Kumar NS, Heinrich M. The Ayurvedic medicine Clitoria ternatea—from traditional use to scientific assessment. Journal of Ethnopharmacology. 2008;120(3):291–301. — PubMed PMID: 18926895 — The standard reference for the plant's traditional indications by plant part, including the purgative uses of seed and root, and the source for the platelet aggregation-inhibiting activity reported for its extracts.
- Oguis GK, Gilding EK, Jackson MA, Craik DJ. Butterfly pea (Clitoria ternatea), a cyclotide-bearing plant with applications in agriculture and medicine. Frontiers in Plant Science. 2019;10:645. — PubMed PMID: 31191573 — The comprehensive species review, and the standard source on butterfly pea's cyclotides, their stability and their insecticidal role.
- Chusak C, Thilavech T, Henry CJ, Adisakwattana S. Acute effect of Clitoria ternatea flower beverage on glycemic response and antioxidant capacity in healthy subjects: a randomized crossover trial. BMC Complementary and Alternative Medicine. 2018;18(1):6. — PubMed PMID: 29310631 — The acute crossover trial in 15 healthy men; relevant here for its adverse-event reporting and for the finding that fasting glucose was unaffected.
- Thilavech T, Adisakwattana S, Channuwong P, Radarit K, Jantarapat K, Ngewlai K, Sonprasan N, Chusak C. Clitoria ternatea flower extract attenuates postprandial lipemia and increases plasma antioxidant status responses to a high-fat meal challenge in overweight and obese participants. Biology (Basel). 2021;10(10):975. — PubMed PMID: 34681074 — The high-fat-meal crossover trial in 16 overweight and obese men; the only other controlled human drinking trial for this plant.
- Assegaf TS, Jusuf NK, Pane YS, Rusda M, Darmani EH, Amin MM, Lubis RD, Bachtiar A. Anti-dandruff effects of butterfly pea flowers (Clitoria ternatea)-based shampoo: a pretest-posttest control study. Narra J. 2024;4(2):e876. — PubMed PMID: 39280272 — The dandruff shampoo trial in 70 young women.
- Fu H, Yang CY, So PB, Yen CH, Wu TH, Yen FL. Assessment of skin safety and anti-pollution activity of Clitoria ternatea L. (butterfly pea) flower extract. Journal of Ethnopharmacology. 2026;356:120739. — PubMed PMID: 41130581 — Laboratory skin-safety and phototoxicity tests of a water extract and an ethanol extract.
- On the acute and sub-chronic toxicology of Clitoria ternatea extracts in animals — a sparse literature, mostly reporting no adverse effect at the doses tested, which is a weak form of reassurance rather than a clearance. — Search PubMed
- On butterfly-pea extracts in hair-growth and follicle models — the thin preliminary literature behind the hair claims, largely in-vitro and cosmetic-science work. — Search PubMed
- On the biology of hair greying and follicular melanocyte stem cell depletion — the actual mechanism that any anti-greying claim would have to address. — Search PubMed
- On androgenetic alopecia and the treatments with established randomized-trial evidence — the comparison that matters for real hair loss. — Search PubMed
- On topical anthocyanins, skin photoprotection and anti-glycation activity — the preliminary basis for the skincare rationale. — Search PubMed
- On botanical extracts as a source of allergic contact dermatitis — the reason to patch-test a new plant-based cosmetic. — Search PubMed
- On legume cross-reactivity and how weakly botanical family predicts clinical allergy — the basis for the measured tone of the allergy section. — Search PubMed
- On traditional emmenagogue and uterine-stimulant reputations of Indian medicinal plants, including aparajita — the ethnobotanical basis for the pregnancy caution, and a literature whose reliability is itself contested. — Search PubMed
Connections
- All Herbs
- Butterfly Pea (Clitoria ternatea) — the main topic page, with forms, preparations, dosage and the full cautions list.
- Antioxidant and Metabolic Claims Examined — the absorption arithmetic behind the ingestible hair and skin claims, and the diabetes-medication interaction in full.
- Anthocyanins and Why It Changes Colour — why a shampoo at pH 5 deposits violet rather than blue.
- Cognition, Mood and Traditional Use — the root-versus-flower problem in its clearest form.
- Alopecia — hair loss, its actual causes, and the treatments with trial evidence.
- Eczema — relevant if you are patch-testing botanical cosmetics on reactive skin.
- Acne — another condition where botanical cosmetic claims outrun the evidence.
- Anthocyanins — the pigment class, its absorption limits and its real evidence base.
- Vitamin C — a topical antioxidant with genuine dermatological formulation science behind it, for comparison.
- Amla — the other great Ayurvedic hair herb, with its own tradition-versus-evidence gap.
- Hibiscus — also used traditionally for hair, and the most common blending partner that turns blue tea purple.
- Rosemary — the hair-and-scalp botanical with the most human trial data, such as it is.
Safety and disclaimer. This page is educational and is not medical advice. Butterfly-pea flower used as a tea, food colouring or topical cosmetic has a long traditional record and no established toxicity signal at those amounts — which means no signal has been found, not that safety has been demonstrated. Concentrated extracts and capsules have not been studied for long-term human use, and no upper limit has been established. The seeds and root are traditionally purgative and are not the tea. There is no human safety data for concentrated extracts during pregnancy, breastfeeding or childhood; a patch test is the standard check for a new topical product; and stopping concentrated extracts about two weeks before planned surgery is the general surgical precaution. In a trial, extract taken with sugar lowered the after-meal rise in glucose and insulin, which matters for people on insulin or a sulfonylurea, and a review lists platelet aggregation-inhibiting activity for the extracts, which matters for people on an anticoagulant. Butterfly pea has not been tested as a treatment for hair loss, a skin condition or any diagnosed illness.